Retrospective Observational Study to Evaluate Long-Term Effectiveness and Safety of Omalizumab Treatment in Real-Life Setting in Allergy Centre of Spain

被引：0
|
作者：
Marquez Hernandez, Dorkas Margarita [1 ]
Bastidas, Jose A. [1 ]
Herraez, Lys [1 ]
Mederos, Elena [1 ]
Enriquez Matas, A. [1 ]
Mielgo Ballesteros, Ruth [1 ]
Fernandez, Consuelo [1 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2016年 / 137卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
35
引用
收藏
页码：AB12 / AB12
页数：1
相关论文
共 50 条
  • [41] Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
    Katja Kollewe
    Claus M. Escher
    Dirk U. Wulff
    Davood Fathi
    Lejla Paracka
    Bahram Mohammadi
    Matthias Karst
    Dirk Dressler
    Journal of Neural Transmission, 2016, 123 : 533 - 540
  • [42] Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience
    Ensina, Luis Felipe
    de Lacerda, Alex Eustaquio
    de Oliveira Machado, Ligia Maria
    Camelo-Nunes, Ines
    Sole, Dirceu
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (06) : 536 - 536
  • [43] Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain
    Nieto-Cid, Maria
    Garriga-Baraut, Teresa
    Plaza-Martin, Ana M.
    Tortajada-Girbes, Miguel
    Torres-Borrego, Javier
    Lozano-Blasco, Jaime
    Moreno-Galarraga, Laura
    del Mar Folque-Gimenez, Ma
    Bosque-Garcia, Montse
    Gaboli, Mirella
    Lopez-Neyra, Alejandro
    Rivas-Juesas, Cristina
    Araceli Caballero-Rabasco, Ma
    Freixa-Benavente, Andrea
    Valdesoiro-Navarrete, Laura
    de Mir-Messa, Ines
    Ballester-Asensio, Esther
    Penin-Anton, Maria
    Romero-Garcia, Raquel
    Navarro-Moron, Juan
    Valenzuela-Soria, Alfredo
    Sanchez-Mateos, Mercedes
    Batlles-Garrido, Jose
    Sanz-Santiago, Veronica
    de Atauri, Avaro Gimeno-Diaz
    Andres-Martin, Anselmo
    Campos-Alonso, Elena
    Gomez-Pastrana, David
    Vazquez-Rodriguez, Elena
    Martinez-Pardo, Luz
    del Rio-Camacho, Genoveva
    Mazon-Ramos, Angel
    Nieto-Garcia, Antonio
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2023, 34 (04)
  • [44] Long-term eltrombopag in children with chronic immune thrombocytopenia: A single-centre extended real-life observational study in China
    Wang, Zhifa
    Wang, Nan
    Juntao, Ouyang
    Ma, Jingyao
    Dong, Shuyue
    Meng, Jinxi
    Liu, Jingjing
    Chen, Zhenping
    Cheng, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 1017 - 1023
  • [45] Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean "real-life" experience
    Tzortzaki, Eleni G.
    Georgiou, Andreas
    Kampas, Dimitrios
    Lemessios, Marinos
    Markatos, Miltiadis
    Adamidi, Tonia
    Samara, Katerina
    Skoula, Georgia
    Damianaki, Aggeliki
    Schiza, Sophia
    Tzanakis, Nikos
    Siafakas, Nikolaos M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2012, 25 (01) : 77 - 82
  • [46] Real-life use and long-term effectiveness results from CIREL - the multi-centre, observational study on irinotecan-eluting transarterial chemoembolization in CRLM
    Taieb, J.
    Arnold, D.
    Prenen, H.
    Sangro, B.
    Pernot, S.
    Zeka, B.
    Kaufmann, N.
    Gjoreski, A.
    Iezzi, R.
    Pereira, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S252 - S252
  • [47] Treatment of Paget's disease of the bone: long-term effect of neridronate in a real-life setting
    Romano, Fiammetta
    Di Benedetto, Elea
    Scarano, Elisabetta
    Riccio, Enrico
    Arianna, Rossana
    Colao, Annamaria
    Di Somma, Carolina
    MINERVA ENDOCRINOLOGY, 2021, 46 (04): : 374 - 383
  • [48] Clinical outcomes with long-term sorafenib treatment: A multicenter, real-life study
    Sacco, R.
    Parodi, S.
    Zolfino, T.
    Saitta, C.
    Marzi, L.
    Simonetti, N.
    Attardo, S.
    Rossa, M.
    Bresci, G.
    Cabibbo, G.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E38 - E38
  • [49] Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
    Megna, Matteo
    Potestio, Luca
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    PSORIASIS-TARGETS AND THERAPY, 2022, 12 : 205 - 212
  • [50] Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
    Megna, Matteo
    Ruggiero, Angelo
    Battista, Teresa
    Marano, Laura
    Cacciapuoti, Sara
    Potestio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
12345